MindBio Therapeutics Corp (CSE:MBIO) Lists its Common Shares on the Canadian Securities Exchange
Leading biotech/biopharm company MindBio lists on the Canadian Securities ExchangePsychedelic medicine fund, Negev Capital is a shareholderSuccessful completion of Phase 1 trial and two fully...
BWVI) Novel Topical Ketamine Delivery
Psycheceutical Bioscience, Inc. Is Developing a Topical Application Of Ketamine Targeted to Relieve PTSD Symptoms Within Minutes and Negate Side EffectsFT. LAUDERDALE, FL / ACCESSWIRE...
Tryp Therapeutics Announces Private Placement of Secured Convertible Debentures for Gross Proceeds of a Minimum of AUD$2,000,000
KELOWNA, BC / ACCESSWIRE / April 12, 2023 / Tryp Therapeutics Inc. ("Tryp" or the "Company") (CSE:TRYP), a clinical-stage biotechnology company focused on developing intravenous-infused...
Initiating Animal Model Studies on Psychedelics Drug Development to Combat a Variety of Neurological Diseases
VANCOUVER, BC / ACCESSWIRE / January 24, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6)(WKN: A3CSSU) (the "Company" or "Core One"), in follow-up to its press...
Positioning Itself as a Full Cycle Psychedelics Supply Chain Solution for Clinicians, Researchers and Other Drug Developers
VANCOUVER, BC / ACCESSWIRE / January 13, 2023 / Core One Labs Inc. (CSE:COOL)(OTCQB:CLABF)(Frankfurt:LD6)(WKN: A3CSSU) (the "Company" or "Core One"), is pleased to announce that...
Lifted Made Signs Agreement to Recoup $1 Million From Vape Device Manufacturer
JACKSONVILLE, FL / ACCESSWIRE / January 3, 2023 / LFTD Partners Inc. (OTCQB:LIFD) (www.LFTDPartners.com) today announced that its wholly-owned subsidiary Lifted Made, Kenosha, Wisconsin (www.LiftedMade.com),...
Ketamine Media Scheduled to Launch North America’s Largest Psilocybin Awareness Network
Ketamine Media announced today that it is in the final stages of launching its digital ecosystem of premium online properties to raise awareness about the...